x

Like our Facebook Page

   
Early Times Newspaper Jammu, Leading Newspaper Jammu
 
Breaking News :   Income Tax fraud: Employees claim to "donate" 50% of their salaries to political parties | SMC smells ‘multi-crore nasty plan’ in executive committee meeting | More BJP wins in elections, more protests it will face from opposition: PM Modi | Despite claiming non-practicing allowance, docs indulge in pvt practice | J&K policies, situation worthy of investment: Amit Shah | India, Africa partnership essential for regional peace: Rajnath Singh | China aims to replace US as global net security provider: Army Chief | J&K Excise Policy 2023-24, introduces new initiatives to boost revenue | Govt transfers 20 JKAS officers | Z-Morh tunnel on Srinagar-Leh Highway to be inaugurated next month: Gadkari | Secretary Health reviews COVID-19 situation with stakeholders | PAN, Aadhaar card linking deadline extended by 3- months | Rahul Gandhi's disqualification from Parliament India's internal matter: Anurag Thakur on US official's statement | Development narrative of BJP 'castle in air', ground reality exactly opposite: RL Gupta | Jammu Police organises T20 Cricket Tournament under Civic Action Programme | High Court upholds life-imprisonment awarded to Hizbul terrorist | Players from J&K to participate in Speedball Championship | Ben Stokes to play as specialist batter at start of IPL 2023 | Mayers or Hooda likely to open with KL Rahul in LSG's first two games | Australian cricket team love to hate Cheteshwar Pujara: Josh Hazlewood | Chennai Super Kings' Ben Stokes to play as a specialist batter at the start of IPL 2023 - Report | Indian Weightlifter Bharali Bedabrate bags World Youth Championships bronze | Australians love to hate Pujara: Hazlewood | GLDM College organizes Road Show | Centre working to reduce logistics cost to GDP to 7.5% in 5 years: Amit Shah | Only filing cases against hate speech won't solve the issue: Supreme Court | Bombay Lawyers' body seeks action against Vice President, Law Minister | Watali moves Delhi HC against charges framed | Easy address change process in Aadhaar major cause of cyber fraud: Police | Cong's chance to regain lost ground 'bleak': Kavinder | Jewelers Awareness Program organized by BIS-JKBO | DC Reasi flags off 'Run for Unity' rally | Budgam Police arrests 4 involved in robbery, stolen property recovered | JCB operator dies in avalanche in J&K's Anantnag | Attendant injured after scuffle with security guard at SDH Sopore | IAF's 'Kargil Courier' airlifted over 3,000 stranded passengers this winter | Kavinder vouches for fair, timely compensation for acquired lands | DDC Rajouri leads meeting to review implementation of PC&PNDT Act | Course on "Investigation of Cyber Crime" commenced | J&K govt gives big push to promotion of 'NADRU' of Dal Lake | District Level NCORD Committee meeting held | Back Issues  
 
news details
Serum Institute seeks inclusion of Covid Jab 'Covovax' in CoWIN portal
1/18/2023 10:48:02 PM
agencies
NEW DELHI, Jan 18: Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
The letter was written by Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), they said.
National Technical Advisory Group on Immunisation (NTAGI) is likely to hold a meeting soon to decide on the matter.
The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two doses of either Covishield or Covaxin.
Its approval was based on recommendations by the subject expert committee (SEC) of the Central Drugs Standard Control Organisation.
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and also in children aged seven to 11 years on June 28 last year subject to certain conditions
Covovax is manufactured through technology transfer from Novavax.
It has been approved by the European Medicines Agency for conditional marketing authorization and was granted emergency-use listing by the World Health Organization (WHO) on December 17, 2021.
In August 2020, US-based vaccine maker Novavax Inc. had earlier announced a license agreement with the SII for the development and commercialization of NVX-CoV2373, its COVID-19 vaccine candidate in India and low-and-middle-income countries.
  Share This News with Your Friends on Social Network  
  Comment on this Story  
 
 
 
Early Times Android App
STOCK UPDATE
  
BSE Sensex
NSE Nifty
 
CRICKET UPDATE
 
 
 
 
 
 
 
 
   
Home About Us Top Stories Local News National News Sports News Opinion Editorial ET Cetra Advertise with Us ET E-paper
 
 
J&K RELATED WEBSITES
J&K Govt. Official website
Jammu Kashmir Tourism
JKTDC
Mata Vaishnodevi Shrine Board
Shri Amarnath Ji Shrine Board
Shri Shiv Khori Shrine Board
UTILITY
Train Enquiry
IRCTC
Matavaishnodevi
BSNL
Jammu Kashmir Bank
State Bank of India
PUBLIC INTEREST
Passport Department
Income Tax Department
JK CAMPA
JK GAD
IT Education
Web Site Design Services
EDUCATION
Jammu University
Jammu University Results
JKBOSE
Kashmir University
IGNOU Jammu Center
SMVDU